By continuing to browse this site, you are agreeing to cookies being used to offer content and services adapted to your interests.
Last week a panel of oncology experts summoned by the FDA voted unanimously in favour of Novartis’ groundbreaking CAR-T cancer therapy.
A by-product of the internet, Big Data technology is now being applied within numerous economic sectors including the asset management industry.
Given our confidence in the sustainability of positive global growth and more hawkish central banks throughout the next quarters, Candriam remains strategically overweight equities and keeps an underweight and short duration on fixed-income for H2 2017.
July 17, 2017
Bond markets and economic news flows have given early signs of a broadening and converging activity cycle, which marks the second step in the global reflation.
In the US, industrial output rose for the fifth consecutive month, helped by gains in mining, while the manufacturing sector rebounded.
Positive week for European Equities.
After the sharp sell-off in sovereign yields over the past weeks, global interest rates recovered.
Markets' figures
July 19, 2017
We note that the overall framework for the euro has turned negative vs. certain currencies (SEK and yen) based primarily on tactical factors and is less positive vs. the US dollar than before.
Activity cycle momentum continues to strengthen in the Eurozone and in Japan as the expansion stage remains well-anchored in both regions.
The slowing debt cycle, tighter credit spreads, and lesser central bank support entice us to take a rather cautious and neutral view on the corporate bond universe.
External risks to EM have declined consistently since the beginning of the year as DM political uncertainty subsided with European elections
June 29, 2017
In an effort to secure comparable workforce reporting from listed companies on an annual basis, Candriam Investors Group has decided to join The Workforce Disclosure Initiative (WDI) which will be officially launched at the end of June 2017.
June 28, 2017
Candriam today announces the launch of a range of specialized ETF strategies.
June 27, 2017
We all know that our body uses our immune system to protect ourselves from various infections but did you know that the same immune system that fights off a nasty winter cold can also be used to cure cancer?
June 26, 2017
Candriam holds a neutral stance on Japanese equities. We think a weaker currency or the resumption of the reflation trade is required for more conviction.
June 22, 2017
The slowing debt cycle, tighter credit spreads, and decreased central bank support (especially if rate hikes are combined with balance sheet normalization) entice us to take a rather cautious and neutral view on the corporate bond universe.
Anton Brender
Chief Economist
Florence Pisani
Global Head of Economic Research
Geoffroy Goenen
Head of Fundamental Europe Equity Management
Isabelle Cabie
Global Head of Responsible Development
Jan Boudewijns
Head of Emerging Equity Management
Koen Popleu
Deputy Head of Fundamental Equity Management
Koen Van de Maele
Global Head of Investment Engineering
Nadège Dufossé
Head of Asset Allocation
Nicolas Forest
Global Head of Fixed Income Management
Patrick Zeenni
Deputy Head of High Yield & Credit Arbitrage management
Philippe Noyard
Head of High Yield & Credit Arbitrage management
Rudi Van den Eynde
Head of Thematic Global Equity
Looking for a fund?
Look it up here...
Contact Us
We value your input and welcome your questions and comments...
CANDRIAM “Conviction AND Responsibility In Asset Management”
One of Europe’s leading asset managers
500+
Experienced professionals
Multi-specialist in traditional, alternative and SRI management
20
Years of experience
Part of New York Life, a Fortune100© company
107.2BN€
Assets under management on March 2017
My country of residence
I confirm I am a
And agree with and will comply to the terms and conditions below:
By clicking on "I agree", you acknowledge having your usual residence in the country you will select. If not, then you acknowledge and accept that you must click on the button "I disagree", in order to return to the home page of this site, where you can then make the right choice. In fact, the information available on this site is only intended for physical persons with their usual residence in the country concerned, or for companies with their registered office in the country selected. Candriam, therefore, has no liability whatsoever for any harm of loss of opportunity resulting from the fact that you were given access to this site after selecting a country other than your own. The information given on this site constitutes neither an offer nor an invitation to negotiate, purchase and/or sell the financial instruments mentioned. By clicking on the "I agree" button below, you acknowledge and accept that the use of and access to the information and/or services accessible via this site, is subject to acceptance of the provisions referred to in the Legal Information which, on the example of this "Important information", constitute the conditions imposed by Candriam for the use of its site. Candriam reserves the right unilaterally and at any time to amend this "Important information", as well as the "Legal information". Your use of the site is subject to the most recent version both of the "Important information" and the "Legal information".
Username
Password
Forgot your password ?
OR
Topics
Highlighted
Authors
Resources
Article 173
